Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01

NCT02311621 · clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
65
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Seattle Children's Hospital

Collaborators